Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism.

Autor: Stujanna, Endin Nokik1, Murakoshi, Nobuyuki1 n.murakoshi@md.tsukuba.ac.jp, Tajiri, Kazuko1, Xu, DongZhu1, Kimura, Taizo1, Qin, Rujie1, Feng, Duo1, Yonebayashi, Saori1, Ogura, Yukino1, Yamagami, Fumi1, Sato, Akira1, Nogami, Akihiko1, Aonuma, Kazutaka1
Zdroj: PLoS ONE. 12/12/2017, Vol. 12 Issue 12, p1-19. 19p.
Databáze: Academic Search Ultimate